Marc M. Baum

2.4k total citations
85 papers, 2.0k citations indexed

About

Marc M. Baum is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Marc M. Baum has authored 85 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 26 papers in Virology and 18 papers in Molecular Biology. Recurrent topics in Marc M. Baum's work include HIV/AIDS Research and Interventions (29 papers), HIV Research and Treatment (26 papers) and Reproductive tract infections research (16 papers). Marc M. Baum is often cited by papers focused on HIV/AIDS Research and Interventions (29 papers), HIV Research and Treatment (26 papers) and Reproductive tract infections research (16 papers). Marc M. Baum collaborates with scholars based in United States, South Africa and France. Marc M. Baum's co-authors include John A. Moss, Manjula Gunawardana, Michael R. Hoffmann, Laura M. Barge, David G. VanderVelde, Paul Webster, Thomas J. Smith, Gregory A. Poskrebyshev, Michael J. Russell and Irina Butkyavichene and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Marc M. Baum

80 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc M. Baum United States 25 570 411 347 346 302 85 2.0k
John A. Moss United States 26 545 1.0× 324 0.8× 184 0.5× 339 1.0× 255 0.8× 69 2.1k
Jose‐Luis Sagripanti United States 28 534 0.9× 104 0.3× 652 1.9× 49 0.1× 292 1.0× 68 2.6k
Jian‐Hua Wang China 33 417 0.7× 66 0.2× 970 2.8× 635 1.8× 275 0.9× 127 3.2k
Anna L. Goodman United Kingdom 19 286 0.5× 46 0.1× 442 1.3× 158 0.5× 441 1.5× 55 2.2k
Paul Smith United States 31 266 0.5× 75 0.2× 1.6k 4.6× 76 0.2× 337 1.1× 122 3.7k
Robert Palmer United States 38 492 0.9× 422 1.0× 2.8k 8.0× 27 0.1× 597 2.0× 88 6.9k
Michael R. Brown United Kingdom 40 571 1.0× 441 1.1× 3.2k 9.3× 16 0.0× 385 1.3× 148 6.2k
Jesús Pérez‐Gil Spain 53 156 0.3× 246 0.6× 2.7k 7.8× 157 0.5× 285 0.9× 234 9.1k
David Rojo Spain 24 479 0.8× 49 0.1× 1.5k 4.2× 111 0.3× 235 0.8× 53 2.5k
Stanley L. Hem United States 43 436 0.8× 284 0.7× 1.4k 3.9× 119 0.3× 552 1.8× 163 5.1k

Countries citing papers authored by Marc M. Baum

Since Specialization
Citations

This map shows the geographic impact of Marc M. Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc M. Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc M. Baum more than expected).

Fields of papers citing papers by Marc M. Baum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc M. Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc M. Baum. The network helps show where Marc M. Baum may publish in the future.

Co-authorship network of co-authors of Marc M. Baum

This figure shows the co-authorship network connecting the top 25 collaborators of Marc M. Baum. A scholar is included among the top collaborators of Marc M. Baum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc M. Baum. Marc M. Baum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Eberhardt, Manfred K., et al.. (2024). Formally Zerovalent Bis(arene) Germylene Complexes of Zirconium and Hafnium. Angewandte Chemie International Edition. 64(8). e202420114–e202420114.
3.
Gallay, Philippe, Christina M. Ramirez, & Marc M. Baum. (2023). Acute antagonism in three-drug combinations for vaginal HIV prevention in humanized mice. Scientific Reports. 13(1). 4594–4594. 1 indexed citations
4.
Gunawardana, Manjula, Simon G. Webster, Paul Webster, et al.. (2022). Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxis. Scientific Reports. 12(1). 8224–8224. 11 indexed citations
5.
Gunawardana, Manjula, Rob Fanter, Simon G. Webster, et al.. (2022). Preclinical Considerations for Long-acting Delivery of Tenofovir Alafenamide from Subdermal Implants for HIV Pre-exposure Prophylaxis. Pharmaceutical Research. 40(7). 1657–1672. 3 indexed citations
6.
Romano, Joseph, Marc M. Baum, Charles Dobard, et al.. (2021). Tenofovir Alafenamide for HIV Prevention: Review of the Proceedings from the Gates Foundation Long-Acting TAF Product Development Meeting. AIDS Research and Human Retroviruses. 37(6). 409–420. 19 indexed citations
7.
Aguirre, Vincent, Paul Webster, Christopher Buser, et al.. (2020). Synthesis and Characterization of Mixed-Valent Iron Layered Double Hydroxides (“Green Rust”). ACS Earth and Space Chemistry. 5(1). 40–54. 13 indexed citations
8.
Barge, Laura M., et al.. (2020). Effects of Geochemical and Environmental Parameters on Abiotic Organic Chemistry Driven by Iron Hydroxide Minerals. Journal of Geophysical Research Planets. 125(11). 24 indexed citations
9.
Gunawardana, Manjula, Simon G. Webster, Patricia Galván, et al.. (2020). Multispecies Evaluation of a Long-Acting Tenofovir Alafenamide Subdermal Implant for HIV Prophylaxis. Frontiers in Pharmacology. 11. 569373–569373. 19 indexed citations
10.
11.
Gallay, Philippe, et al.. (2018). Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice. PubMed. 12(1). 1–13. 13 indexed citations
12.
Smith, James M., John A. Moss, Priya Srinivasan, et al.. (2017). Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model. PLoS ONE. 12(10). e0185946–e0185946. 29 indexed citations
13.
Srinivasan, Priya, John A. Moss, Manjula Gunawardana, et al.. (2016). Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures. PLoS ONE. 11(6). e0157061–e0157061. 24 indexed citations
14.
Ursell, Luke K., Manjula Gunawardana, John A. Moss, et al.. (2013). Comparison of the vaginal microbial communities in women with recurrent genital HSV receiving acyclovir intravaginal rings. Antiviral Research. 102. 87–94. 20 indexed citations
15.
Keller, Marla J., Amanda Malone, Colleen Carpenter, et al.. (2012). Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ring. Journal of Antimicrobial Chemotherapy. 67(8). 2005–2012. 18 indexed citations
16.
Baum, Marc M., Irina Butkyavichene, Sean Kennedy, et al.. (2012). An Intravaginal Ring for the Simultaneous Delivery of Multiple Drugs. Journal of Pharmaceutical Sciences. 101(8). 2833–2843. 73 indexed citations
17.
Hoffmann, Michael R., John A. Moss, & Marc M. Baum. (2011). Artificial photosynthesis: semiconductor photocatalytic fixation of CO2 to afford higher organic compounds. Dalton Transactions. 40(19). 5151–5151. 128 indexed citations
18.
Key, David L., Jean‐Eudes Petit, Catherine Bonnet, et al.. (2011). Integrated method for the measurement of trace atmospheric bases. 1 indexed citations
19.
Baum, Marc M., et al.. (2005). Non-invasive measurement of cardiac output: Evaluation of new infrared absorption spectrometer. Respiratory Physiology & Neurobiology. 153(2). 191–201. 3 indexed citations
20.
Baum, Marc M.. (1973). The dangerous sky a history of aviation medicine. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John A. Moss Breakdown of academic impact, for papers by Jose‐Luis Sagripanti Breakdown of academic impact, for papers by Jian‐Hua Wang Breakdown of academic impact, for papers by Anna L. Goodman Breakdown of academic impact, for papers by Paul Smith Breakdown of academic impact, for papers by Robert Palmer Breakdown of academic impact, for papers by Michael R. Brown Breakdown of academic impact, for papers by Jesús Pérez‐Gil Breakdown of academic impact, for papers by David Rojo Breakdown of academic impact, for papers by Stanley L. Hem
Rankless by CCL
2026